First Advantage Co. (NYSE:FA) Given Average Rating of “Hold” by Analysts

First Advantage Co. (NYSE:FA) has earned a consensus recommendation of “Hold” from the seven ratings firms that are currently covering the company, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $19.25.

A number of analysts recently weighed in on FA shares. Zacks Research cut shares of First Advantage from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 5th. JPMorgan Chase & Co. reduced their price objective on First Advantage from $21.00 to $17.00 and set an “overweight” rating on the stock in a research note on Friday, November 7th.

First Advantage Stock Down 1.4%

Shares of NYSE:FA opened at $15.50 on Tuesday. The stock has a 50-day simple moving average of $14.18 and a 200-day simple moving average of $15.34. The stock has a market capitalization of $2.70 billion, a P/E ratio of 516.67 and a beta of 1.18. First Advantage has a 1 year low of $11.95 and a 1 year high of $20.27. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.85 and a current ratio of 3.85.

First Advantage (NYSE:FA) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.02. First Advantage had a net margin of 0.65% and a return on equity of 13.16%. During the same quarter in the previous year, the business earned $0.26 EPS. The company’s quarterly revenue was up 105.5% on a year-over-year basis. First Advantage has set its FY 2025 guidance at 0.980-1.020 EPS. Equities analysts forecast that First Advantage will post 0.74 earnings per share for the current year.

Hedge Funds Weigh In On First Advantage

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Parkside Financial Bank & Trust raised its stake in shares of First Advantage by 22.8% during the second quarter. Parkside Financial Bank & Trust now owns 7,164 shares of the company’s stock valued at $119,000 after purchasing an additional 1,328 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in First Advantage by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,567 shares of the company’s stock valued at $501,000 after purchasing an additional 1,471 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in First Advantage by 6.5% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 26,425 shares of the company’s stock valued at $439,000 after purchasing an additional 1,614 shares in the last quarter. SG Americas Securities LLC increased its stake in First Advantage by 22.6% during the 3rd quarter. SG Americas Securities LLC now owns 9,211 shares of the company’s stock worth $142,000 after buying an additional 1,700 shares during the period. Finally, Ameritas Investment Partners Inc. lifted its holdings in First Advantage by 29.1% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 8,088 shares of the company’s stock worth $134,000 after buying an additional 1,821 shares in the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

About First Advantage

First Advantage is a global provider of background screening, identity verification and workforce risk management solutions. The company delivers a comprehensive suite of services that help employers verify candidate credentials, manage regulatory compliance and mitigate risk throughout the employee lifecycle. Its platform is built to integrate with leading human capital management and applicant tracking systems, enabling a seamless and scalable experience for organizations of all sizes.

The company’s core offerings include pre-employment and continuous background screening, digital identity verification, drug and health testing, and ongoing employee monitoring.